Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Communications Medicine
|
May 30, 2026
Health-system barriers and missed opportunities in cardiovascular care in Sierra Leone: a scoping review
Mohamed B Jalloh, Fatima Jalloh, Mamadu Baldeh, et al.
Atherosclerosis
|
October 8, 2020
Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease
Fabian J Brunner, Friederike Kröger, Christopher Blaum, et al.
Clinical Transplantation
|
June 9, 2025
Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease
Lukas Köster, Jessica Weimann, Alexander Bernhard, et al.
Atherosclerosis
|
April 5, 2025
Prognostic utility of high-sensitivity troponins according to atherosclerotic vascular disease severity
Julia Rohde, Fabian J Brunner, Alina Goßling, et al.
European Journal of Preventive Cardiology
|
November 26, 2024
Association of Modifiable Lifestyle Risk Factors with High-Sensitivity Troponin T and I Concentrations and Clinical Outcomes
Benjamin Bay, Luise Pieper, Alina Goßling, et al.
Clinical Therapeutics
|
August 31, 2021
Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort
Christopher Blaum, Fabian J Brunner, Alina Goßling, et al.
European Journal of Preventive Cardiology
|
April 10, 2021
Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population
Christopher Blaum, Fabian J Brunner, Friederike Kröger, et al.
European Journal of Preventive Cardiology
|
February 13, 2021
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort
Christopher Blaum, Moritz Seiffert, Alina Goßling, et al.
Journal of the American Heart Association
|
July 21, 2022
Association of High-Sensitivity Troponin T and I Blood Concentrations With All-Cause Mortality and Cardiovascular Outcome in Stable Patients-Results From the INTERCATH Cohort
Benjamin Bay, Alina Goßling, Christopher M Blaum, et al.
Public Health
|
November 11, 2025
Telemedicine as a healthcare delivery model for crisis response during the COVID-19 pandemic in Nepal
Arun Gautam, Urza Bhattarai, Sigiriya Aebischer Perone, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Communications Medicine
|
May 30, 2026
Health-system barriers and missed opportunities in cardiovascular care in Sierra Leone: a scoping review
Mohamed B Jalloh, Fatima Jalloh, Mamadu Baldeh, et al.
Atherosclerosis
|
October 8, 2020
Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease
Fabian J Brunner, Friederike Kröger, Christopher Blaum, et al.
Clinical Transplantation
|
June 9, 2025
Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease
Lukas Köster, Jessica Weimann, Alexander Bernhard, et al.
Atherosclerosis
|
April 5, 2025
Prognostic utility of high-sensitivity troponins according to atherosclerotic vascular disease severity
Julia Rohde, Fabian J Brunner, Alina Goßling, et al.
European Journal of Preventive Cardiology
|
November 26, 2024
Association of Modifiable Lifestyle Risk Factors with High-Sensitivity Troponin T and I Concentrations and Clinical Outcomes
Benjamin Bay, Luise Pieper, Alina Goßling, et al.
Clinical Therapeutics
|
August 31, 2021
Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort
Christopher Blaum, Fabian J Brunner, Alina Goßling, et al.
European Journal of Preventive Cardiology
|
April 10, 2021
Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population
Christopher Blaum, Fabian J Brunner, Friederike Kröger, et al.
European Journal of Preventive Cardiology
|
February 13, 2021
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort
Christopher Blaum, Moritz Seiffert, Alina Goßling, et al.
Journal of the American Heart Association
|
July 21, 2022
Association of High-Sensitivity Troponin T and I Blood Concentrations With All-Cause Mortality and Cardiovascular Outcome in Stable Patients-Results From the INTERCATH Cohort
Benjamin Bay, Alina Goßling, Christopher M Blaum, et al.
Public Health
|
November 11, 2025
Telemedicine as a healthcare delivery model for crisis response during the COVID-19 pandemic in Nepal
Arun Gautam, Urza Bhattarai, Sigiriya Aebischer Perone, et al.
Page
of 3